Company records / carthera.eu

CarThera

CarThera (carthera.eu): no confident changes recorded yet; website history since November 2026. Homepage last checked 13 November 2026.

First recorded website

Observed 13 November 2026

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

GLIOBLASTOMA and CNS DISEASES Revolutionizing brain treatments

Revolutionizing severe brain disease treatments

Homepage

Funding statements on the website: round reaches €42M December 11, 2023 - Carthera announces an additional €4.5M in funding to complement its Series B financing round, bringing the total raised to €42M ($45M).

current websiteHistorical capture not publicly availableLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

Seen November 2026 · 1 capture · latest observed messagingGLIOBLASTOMA and CNS DISEASES Revolutionizing brain treatments
Revolutionizing severe brain disease treatments
This wording observed 13 November 2026.
current websiteHistorical capture not publicly available

Companies in the same space

Other funded startups with the most similar descriptions of what they do. This does not mean they compete directly.

PsiThera psithera.com
Switch Therapeutics switchthera.com
Accent Therapeutics accenttx.com
Thyra thyra.eu

Cite this record

StartupHistory, “CarThera” company record, https://startuphistory.org/c/carthera.eu

Machine-readable: /c/carthera.eu.json. How changes are found: method.